Cefmax

   
Google
 
Web NewDrugInformation.com

Cefmax


Drug - Cefmax
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Cefmenoxime Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - EQ 500MG BASE/VIAL
The potency of the active ingredient(s), Cefmenoxime Hydrochloride. May repeat for multiple part products.

Applicant - TAP PHARM
The firm name holding legal responsibility for Cefmax. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 050571
The FDA assigned number to Cefmax. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Cefmax. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 30, 1987
The date Cefmax was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Cefmax. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Cefmax is in. Format is RX, OTC, DISCN.

Applicant Full Name - Tap Pharmaceutical Products Inc
The full name of the firm holding legal responsibility for the new application of Cefmax.

Cefmax